• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis-going beyond treat to target.行动呼吁:将健康实践纳入类风湿关节炎的整体管理计划——超越治疗目标。
RMD Open. 2021 Dec;7(3). doi: 10.1136/rmdopen-2021-001959.
2
Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.评估类风湿关节炎和脊柱关节炎患者信念的问卷的制定和应用。
Clin Rheumatol. 2018 Oct;37(10):2649-2657. doi: 10.1007/s10067-018-4172-5. Epub 2018 Jun 12.
3
Incorporating the treat-to-target concept in rheumatoid arthritis.将治疗达标理念应用于类风湿关节炎。
J Manag Care Pharm. 2012 Nov-Dec;18(9):1-18. doi: 10.18553/jmcp.2012.18.S9-A.1.
4
Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.目标治疗类风湿关节炎:使用患者意见实时匿名联络系统评估患者观点:RA T2T PORTAL 研究。
Int J Rheum Dis. 2019 May;22(5):874-879. doi: 10.1111/1756-185X.13514. Epub 2019 Feb 22.
5
A 30-Day Adjunct Wellness Intervention for the Management of Extra-Articular Symptoms of Rheumatoid Arthritis: A Formative Study.一项为期 30 天的补充性健康干预措施,用于治疗类风湿关节炎的关节外症状:形成性研究。
J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X221113330. doi: 10.1177/2515690X221113330.
6
Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.群组认知行为方案对减轻类风湿关节炎疲劳的影响:RAFT RCT 伴有经济和定性评估。
Health Technol Assess. 2019 Oct;23(57):1-130. doi: 10.3310/hta23570.
7
Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.使用患者报告结局测量信息系统(PROMIS)对类风湿关节炎的达标治疗(T2T)方法进行标准化和个性化:以患者为中心的治疗优先级的基线研究结果
Clin Rheumatol. 2017 Aug;36(8):1729-1736. doi: 10.1007/s10067-017-3731-5. Epub 2017 Jun 26.
8
The optimal combination therapy for the treatment of early rheumatoid arthritis.早期类风湿关节炎治疗的最佳联合疗法。
Expert Opin Pharmacother. 2015;16(11):1615-25. doi: 10.1517/14656566.2015.1056735. Epub 2015 Jun 10.
9
Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?在临床实践中采用达标治疗策略管理类风湿关节炎:在多民族的马来西亚人群中我们处于什么位置?
Rheumatol Int. 2017 Jun;37(6):905-913. doi: 10.1007/s00296-017-3705-6. Epub 2017 Apr 7.
10
Outcome assessments in rheumatoid arthritis.类风湿关节炎的疗效评估。
Curr Rheumatol Rep. 2013 Nov;15(11):370. doi: 10.1007/s11926-013-0370-y.

引用本文的文献

1
Towards better personalized care in rheumatoid arthritis.迈向类风湿关节炎更优质的个性化治疗。
Rheumatology (Oxford). 2025 Mar 1;64(Supplement_2):ii1-ii2. doi: 10.1093/rheumatology/keaf026.
2
Real-World-Evidence of Digital Health Applications (DiGAs) in Rheumatology: Insights from the DiGAReal Registry.风湿病学中数字健康应用(DiGAs)的真实世界证据:来自DiGAReal注册研究的见解
Rheumatol Ther. 2025 Apr;12(2):267-282. doi: 10.1007/s40744-025-00744-y. Epub 2025 Jan 21.
3
Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases.用于提高药物和生物制品疗效的数字疗法:支持慢性病药物+数字联合疗法开发的临床前和临床研究
J Clin Med. 2024 Jan 11;13(2):403. doi: 10.3390/jcm13020403.
4
Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis.针对类风湿关节炎高危人群的综合非药物性护理。
Rheumatol Int. 2024 Mar;44(3):413-423. doi: 10.1007/s00296-023-05507-y. Epub 2024 Jan 5.
5
Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA).移动健康自我管理干预类风湿关节炎的效果和可行性:一项实用、多中心、随机对照试验的研究方案(AEGORA)。
Trials. 2023 Oct 28;24(1):697. doi: 10.1186/s13063-023-07733-y.
6
MITIG.RA: study protocol of a tailored psychological intervention for managing fatigue in rheumatoid arthritis randomized controlled trial.MITIG.RA:一项针对类风湿关节炎患者疲劳管理的个体化心理干预随机对照试验研究方案。
Trials. 2023 Oct 6;24(1):651. doi: 10.1186/s13063-023-07692-4.
7
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease.优化生物性抗 TNF-α 制剂在中度活跃性类风湿关节炎患者中的应用途径。
BMC Med. 2023 Feb 14;21(1):55. doi: 10.1186/s12916-023-02746-5.
8
Real-world usage of digital health applications (DiGA) in rheumatology: results from a German patient survey.真实世界中数字健康应用程序(DiGA)在风湿病学中的使用:来自德国患者调查的结果。
Rheumatol Int. 2023 Apr;43(4):713-719. doi: 10.1007/s00296-022-05261-7. Epub 2022 Dec 21.
9
Adherence to Subcutaneous Anti-Tumour Necrosis Factor Treatment in a Cohort of Patients with Rheumatoid Arthritis Before and After the Implementation of a Comprehensive Care Model.在实施综合护理模式前后,一组类风湿关节炎患者对皮下注射抗肿瘤坏死因子治疗的依从性
Biologics. 2022 Nov 21;16:199-209. doi: 10.2147/BTT.S385422. eCollection 2022.
10
Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes.应对类风湿关节炎初始抗TNF治疗反应不足:优化治疗效果
Ther Adv Musculoskelet Dis. 2022 Aug 16;14:1759720X221114101. doi: 10.1177/1759720X221114101. eCollection 2022.

本文引用的文献

1
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.2021年美国风湿病学会类风湿关节炎治疗指南
Arthritis Rheumatol. 2021 Jul;73(7):1108-1123. doi: 10.1002/art.41752. Epub 2021 Jun 8.
2
Effectiveness of self-management interventions in inflammatory arthritis: a systematic review informing the 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis.自我管理干预在炎症性关节炎中的疗效:一项系统评价,为 2021 年 EULAR 炎症性关节炎患者自我管理策略实施建议提供信息。
RMD Open. 2021 May;7(2). doi: 10.1136/rmdopen-2021-001647.
3
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis.2021 年 EULAR 炎症性关节炎患者自我管理策略实施建议。
Ann Rheum Dis. 2021 Oct;80(10):1278-1285. doi: 10.1136/annrheumdis-2021-220249. Epub 2021 May 7.
4
Portuguese multidisciplinary recommendations for non-pharmacological and non-surgical interventions in patients with rheumatoid arthritis.葡萄牙多学科推荐类风湿关节炎患者的非药物和非手术干预措施。
Acta Reumatol Port. 2021 Jan-Mar;46(1):40-54.
5
Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison.在初治生物制剂或传统合成疾病修饰抗风湿药物的类风湿关节炎患者中,巴瑞替尼与阿达木单抗、托珠单抗和托法替布单药治疗相比,改善疼痛和身体功能的疗效比较:匹配调整间接比较。
RMD Open. 2020 Apr;6(1). doi: 10.1136/rmdopen-2019-001131.
6
Exergaming as an Additional Tool in Rehabilitation of Young Patients with Rheumatoid Arthritis: A Pilot Randomized Controlled Trial.电子游戏作为类风湿关节炎年轻患者康复治疗的一种辅助手段:一项初步随机对照试验。
Games Health J. 2020 Oct;9(5):368-375. doi: 10.1089/g4h.2019.0167. Epub 2020 Apr 21.
7
Circulating Pro- and Anti-Inflammatory Metabolites and Its Potential Role in Rheumatoid Arthritis Pathogenesis.循环促炎和抗炎代谢物及其在类风湿关节炎发病机制中的潜在作用。
Cells. 2020 Mar 30;9(4):827. doi: 10.3390/cells9040827.
8
Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA)-a randomized, controlled crossover trial indicating effects on disease activity.类风湿关节炎的抗炎饮食(ADIRA)——一项随机对照交叉试验表明其对疾病活动的影响。
Am J Clin Nutr. 2020 Jun 1;111(6):1203-1213. doi: 10.1093/ajcn/nqaa019.
9
Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis.类风湿关节炎患者抗炎饮食(ITIS饮食)的设计
Contemp Clin Trials Commun. 2020 Jan 21;17:100524. doi: 10.1016/j.conctc.2020.100524. eCollection 2020 Mar.
10
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.EULAR 推荐的类风湿关节炎治疗策略:2019 年更新版(使用合成和生物疾病修正抗风湿药物)
Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22.

行动呼吁:将健康实践纳入类风湿关节炎的整体管理计划——超越治疗目标。

Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis-going beyond treat to target.

机构信息

Botnar Research Centre, NDORMS, University of Oxford, Oxford, UK

Transparency in Healthcare B.V, University of Twente, Hengelo, The Netherlands.

出版信息

RMD Open. 2021 Dec;7(3). doi: 10.1136/rmdopen-2021-001959.

DOI:10.1136/rmdopen-2021-001959
PMID:34893537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8666892/
Abstract

This expert opinion article explores the strategy of adopting a holistic approach to the management of rheumatoid arthritis (RA) by incorporating the wellness practices of exercise, optimised sleep, optimised nutrition, mindfulness, social connectedness and positive emotions into the management plan. The aim is to attain optimal health for each patient beyond that achievable by limiting disease management to pharmacological treatment to attain the lowest achievable composite scores of disease activity, as recommended with the current treat-to-target approach, and addressing the recent recognition of pain control as a key patient-reported outcome. Incorporating wellness practices into a busy clinical setting requires creativity and customisation based on the individual practice setting and the individual needs of each patient. Such practices can help people living with RA to achieve optimum wellness through the introduction of measures-according to individual need-designed to improve the aspects of life most impacted for that person, thereby complementing treat-to-target and pain control strategies with pharmacological agents. Clinicians must consider wellness practices in addition to treat-to-target pharmacological agents for the holistic management of people with RA.

摘要

这篇专家观点文章探讨了通过将锻炼、优化睡眠、优化营养、正念、社交联系和积极情绪等健康实践纳入管理计划,采用整体方法来管理类风湿关节炎(RA)的策略。其目的是通过将疾病管理限制在药物治疗上,以达到最低的疾病活动综合评分,从而实现每个患者的最佳健康,这是目前的达标治疗方法所推荐的,同时也满足了最近对疼痛控制作为关键患者报告结果的认识。在繁忙的临床环境中纳入健康实践需要根据个人的实践环境和每个患者的个体需求进行创造性和定制化。这些实践可以通过引入根据个人需求设计的措施,帮助 RA 患者改善对其个人影响最大的生活方面,从而通过药物治疗来补充达标治疗和疼痛控制策略,从而实现最佳的健康。临床医生在进行 RA 患者的整体管理时,必须考虑健康实践,而不仅仅是达标治疗的药物治疗。